Nixed by the FDA, Ther­a­peu­tic­sMD is now plan­ning a long-shot bid to re­verse the de­ci­sion

Ther­a­peu­tic­sMD al­ready flagged that the FDA was about to re­ject its ap­pli­ca­tion for TX-004HR, a pro­posed new ther­a­py to treat vagi­nal pain dur­ing in­ter­course …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA